Investors must take note of EyePoint Inc’s (EYPT) performance last week, which was -0.88%.

Shaun Noe

EyePoint Inc (NASDAQ: EYPT) kicked off on Tuesday, up 3.23% from the previous trading day, before settling in for the closing price of $16.4. Over the past 52 weeks, EYPT has traded in a range of $3.91-$19.11.

A company in the Healthcare sector has jumped its sales by 15.65% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -30.27%. With a float of $73.29 million, this company’s outstanding shares have now reached $82.79 million.

EyePoint Inc (EYPT) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of EyePoint Inc is 11.47%, while institutional ownership is 74.65%. The most recent insider transaction that took place on Dec 04 ’25, was worth 942,240. In this transaction Former 10% Owner of this company sold 60,000 shares at a rate of $15.70, taking the stock ownership to the 8,265,000 shares. Before that another transaction happened on Dec 04 ’25, when Company’s Director sold 9,300 for $15.11, making the entire transaction worth $140,477. This insider now owns 206,547 shares in total.

EyePoint Inc (EYPT) Latest Financial update

In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.64 earnings per share (EPS), lower than consensus estimate (set at -0.48) by -0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -30.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.54% during the next five years compared to 15.65% growth over the previous five years of trading.

EyePoint Inc (NASDAQ: EYPT) Trading Performance Indicators

Take a look at EyePoint Inc’s (EYPT) current performance indicators. Last quarter, stock had a quick ratio of 7.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 33.10.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.99, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -2.89 in one year’s time.

Technical Analysis of EyePoint Inc (EYPT)

Let’s dig in a bit further. During the last 5-days, its volume was 1.03 million. That was better than the volume of 0.93 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 48.71%.

During the past 100 days, EyePoint Inc’s (EYPT) raw stochastic average was set at 77.55%, which indicates a significant increase from 60.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.98 in the past 14 days, which was higher than the 0.84 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $13.48, while its 200-day Moving Average is $10.11. However, in the short run, EyePoint Inc’s stock first resistance to watch stands at $17.47. Second resistance stands at $18.00. The third major resistance level sits at $18.61. If the price goes on to break the first support level at $16.33, it is likely to go to the next support level at $15.72. The third support level lies at $15.19 if the price breaches the second support level.

EyePoint Inc (NASDAQ: EYPT) Key Stats

The company with the Market Capitalisation of 1.40 billion has total of 82,787K Shares Outstanding. Its annual sales at the moment are 43,270 K in contrast with the sum of -130,870 K annual income. Company’s last quarter sales were recorded 970 K and last quarter income was -59,730 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.